ALPA SANGHVI: Open Payments
NPI 1174610976 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 24 payments from 12 companies in 2025. Trend: 2023 $805 · 2024 $537 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $169 |
| ABBVIE INC. | 2 | $150 |
| Otsuka America Pharmaceutical, Inc. | 2 | $134 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Alkermes, Inc. | 2 | $51 |
| Corium, LLC | 2 | $45 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| Vertical Pharmaceuticals, LLC | 2 | $40 |
| Lundbeck LLC | 2 | $39 |
| Noven Therapeutics, LLC | 2 | $34 |
Products named: REXULTI, CAPLYTA, VRAYLAR, TRINTELLIX, LYBALVI, Azstarys, Jornay PM, Relexxii.
Industry payments across AZ — which companies pay providers there.
